Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Thailand Begins Coronavirus Vaccine Trials on Monkeys

by Global Biodefense Staff
May 23, 2020
Thailand Begins Coronavirus Vaccine Trials on Monkeys

Credit: Louis Reed / Unsplash

Thailand’s National Vaccine Institute (NVI) at Chulalongkorn University today began testing a trial vaccine against the novel coronavirus on non-human primates after positive trials in mice, said Taweesin Wisanuyothin, spokesman for the government’s Centre for COVID-19 Situation Administration.

The Thai vaccine uses messenger RNA (mRNA) which prompts body cells to produce antigens, molecules on the surface of viruses, that spur the immune system into action.1

NVI director Dr. Nakorn Premsri noted that if animal testing phase shows convincing results by stimulating the creation of antibodies, the vaccine will move to multi-phase human trials in progressively larger cohorts.2

The NVI is reportedly preparing to sign a Memorandum of Understanding (MoU) with Chinese partners to test a COVID-19 vaccine in Thailand. The Thai

government plans to include a technology transfer aspect to the agreement so that Thailand also can be a producer of the vaccines.3

READ MORE

1. Thailand begins coronavirus vaccine trials on monkeys Reuters

2. Thai National Vaccines Institute tests COVID-19 vaccine in animals XinhuaNet

3. A new direction for China biopharma Bangkok Post

Tags: Animal ModelsClinical TrialsCoronavirusCOVID-19Editor PickmRNASARS-CoV-2Vaccines

Related Posts

Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC